FindMyKOL

Top experts by indication / Oncology

Most active experts in Neuro-Oncology / Glioma

2026 edition, data as of October 26, 2026

461 key opinion leaders in the directory are tagged to Neuro-Oncology / Glioma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.

Most registered trials

Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 194 of the 461 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.

#Experttrials
1David ReardonDana-Farber Cancer Institute, MA25 trials
2Patrick WenDana-Farber Cancer Institute19 trials
3Manmeet AhluwaliaBaptist Health Miami Cancer Institute, FL12 trials
4Jana PortnowCity of Hope, CA11 trials
5Andrew BrennerUT Health San Antonio, TX9 trials
6Howard FineNY7 trials
7Mustafa KhasrawNY7 trials
8Katherine WarrenHarvard University, MA7 trials
9Jiayi HuangMO7 trials
10Stuart GrossmanMD7 trials
11Evanthia GalanisMayo Clinic, MN7 trials
12Kevin CamphausenNational Cancer Institute (NCI), MD7 trials
13Eric LeuthardtWashington University School of Medicine in St. Louis, MO6 trials
14Gregory FriedmanThe University of Texas MD Anderson Cancer Center, TX5 trials
15Helen ShihMA5 trials
16Priya KumthekarNorthwestern University Feinberg School of Medicine, IL5 trials
17Glenn LesserWake Forest University School of Medicine, NC5 trials
18Nadia LaackMayo Clinic, MN5 trials
19Carl KoschmannUniversity of Michigan, MI4 trials
20Susan ChiMA4 trials
21Andrew ClusterSt. Louis Children's Hospital, MO4 trials
22Tanner JohannsWashington University School of Medicine in St. Louis, MO4 trials
23Tobey MacdonaldDC4 trials
24John BuattiUniversity of Iowa Health Care, IA4 trials
25Minesh MehtaFlorida International University Herbert Wertheim College of Medicine3 trials

Most cited

Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 44 of the 461 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.

#Expertcitations
1Patrick WenDana-Farber Cancer Institute89,244 citations
2Minesh MehtaFlorida International University Herbert Wertheim College of Medicine71,705 citations
3David ReardonDana-Farber Cancer Institute, MA63,926 citations
4John HainsworthSarah Cannon Research Institute, TN58,030 citations
5Jann SarkariaMayo Clinic, MN32,285 citations
6Alexander SpiraVirginia Cancer Specialists, VA29,600 citations
7Evanthia GalanisMayo Clinic, MN27,798 citations
8Bruce KorfUniversity of Alabama at Birmingham, AL27,313 citations
9John BuattiUniversity of Iowa Health Care, IA24,943 citations
10Manmeet AhluwaliaBaptist Health Miami Cancer Institute, FL21,233 citations
11Stuart GrossmanMD20,489 citations
12Kevin CamphausenNational Cancer Institute (NCI), MD19,536 citations
13Steven DuboisDana-Farber Cancer Institute, MA18,621 citations
14Matthias KarajannisNY17,749 citations
15Howard SafranBrown University, RI15,235 citations
16Eric LeuthardtWashington University School of Medicine in St. Louis, MO15,137 citations
17Alberto BroniscerTN14,246 citations
18Roxana DroncaMayo Clinic, FL13,753 citations
19Lakshmi NayakHarvard University, MA12,222 citations
20Ayal AizerBrigham and Women's Hospital, MA11,756 citations
21Tobey MacdonaldDC11,334 citations
22Glenn LesserWake Forest University School of Medicine, NC10,515 citations
23Steven ChmuraUniversity of Chicago, IL10,257 citations
24Jana PortnowCity of Hope, CA9,814 citations
25Ranjit BindraYale School of Medicine, CT9,725 citations

Most NIH awards

NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 35 of the 461 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.

#Expertawards
1Jann SarkariaMayo Clinic, MN19 awards
2Evanthia GalanisMayo Clinic, MN13 awards
3Bruce KorfUniversity of Alabama at Birmingham, AL10 awards
4Eric LeuthardtWashington University School of Medicine in St. Louis, MO9 awards
5David AshleyNC8 awards
6Stuart GrossmanMD6 awards
7Andrew BrennerUT Health San Antonio, TX6 awards
8John BuattiUniversity of Iowa Health Care, IA6 awards
9Mark KieranMA5 awards
10Ranjit BindraYale School of Medicine, CT5 awards
11Jana PortnowCity of Hope, CA5 awards
12Patrick WenDana-Farber Cancer Institute4 awards
13Carl KoschmannUniversity of Michigan, MI4 awards
14Tobey MacdonaldDC4 awards
15Hui-Kuo ShuGA4 awards
16Glenn LesserWake Forest University School of Medicine, NC4 awards
17Howard FineNY3 awards
18Theodore JohnsonAugusta University, GA3 awards
19Steven DuboisDana-Farber Cancer Institute, MA3 awards
20Pavel KleinMid-Atlantic Epilepsy and Sleep Center, MD3 awards
21David ReardonDana-Farber Cancer Institute, MA2 awards
22Gregory FriedmanThe University of Texas MD Anderson Cancer Center, TX2 awards
23Helen ShihMA2 awards
24Adam DickerPA2 awards
25John HoffmanPA2 awards

Most congress contributions

Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 16 of the 461 people tagged to this indication have at least 2 registered trials in it and this count on record; the 16 highest are listed. Source: Congress abstracts, DOI-verified.

#Expertcontributions
1John HainsworthSarah Cannon Research Institute, TN194 contributions
2Steven DuboisDana-Farber Cancer Institute, MA126 contributions
3Kevin CamphausenNational Cancer Institute (NCI), MD120 contributions
4Jann SarkariaMayo Clinic, MN108 contributions
5Glenn LesserWake Forest University School of Medicine, NC106 contributions
6Andrew BrennerUT Health San Antonio, TX97 contributions
7Nadia LaackMayo Clinic, MN86 contributions
8Ranjit BindraYale School of Medicine, CT85 contributions
9John BuattiUniversity of Iowa Health Care, IA75 contributions
10Roxana DroncaMayo Clinic, FL70 contributions
11Steven ChmuraUniversity of Chicago, IL65 contributions
12Evanthia GalanisMayo Clinic, MN51 contributions
13Priya KumthekarNorthwestern University Feinberg School of Medicine, IL48 contributions
14Jana PortnowCity of Hope, CA23 contributions
15Bruce KorfUniversity of Alabama at Birmingham, AL3 contributions
16Eric LeuthardtWashington University School of Medicine in St. Louis, MO3 contributions

Emerging

32 of the 461 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.

Nabil AhmedHouston Methodist, TX
Shahab AsgharzadehUniversity of Southern California, CA
Tracy BatchelorBrigham and Women's Hospital, MA
Thomas BeckhamThe University of Texas MD Anderson Cancer Center, TX
Kelsey BertrandSt. Jude Children's Research Hospital, TN
Kevin BielamowiczAR
Markus BredelUniversity of Miami, FL
Nathan DahlMorgan Adams Foundation, CO
Michael FetellTeva Pharmaceuticals, PA
Antonio FojoColumbia University Irving Medical Center, NY
Sangeeta GoswamiThe University of Texas MD Anderson Cancer Center, TX
Amyn HabibVA North Texas Health Care System, TX
Comron HassanzadehThe University of Texas MD Anderson Cancer Center, TX
Meenakshi HegdeHouston Methodist, TX
Daniel HigginsonMemorial Sloan Kettering Cancer Center, NY
Sarah InjacTX
Haruka ItakuraStanford University School of Medicine, CA
David KramUniversity of North Carolina at Chapel Hill, NC
Enrico LallanaKaiser Permanente, CA
Benison LauPA
Theodore LawrenceUniversity of Michigan, MI
Asher MarksYale School of Medicine, CT
Amol MehtaFL
Shoba NavaiBaylor College of Medicine, TX
Bilal OmerBaylor College of Medicine, TX

How these tables are computed

The cohort is every profile in the directory tagged to Neuro-Oncology / Glioma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.

Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.

The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.

What is deliberately absent

Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.

Filter, sort and open every Neuro-Oncology / Glioma profile in the directory